患者如何看待姑息治疗?一项造血干细胞移植受者的全国性调查
该多中心横断面调查纳入250例自体或异基因造血干细胞移植后3至12个月的受者,评估其对姑息治疗的熟悉度、知识和看法及未满足的姑息治疗需求。44.3%(109/249)报告对姑息治疗知识有限,52%(127/245)表示熟悉姑息治疗;多数患者听到姑息治疗一词时感到有希望(54%)和安心(50%),83%认为转诊至姑息治疗表明医生关心其状况。多变量分析中,对姑息治疗知识更丰富的患者更可能有积极看法(B=7.54,标准误=1.61,P<.001)。
要点
- 移植受者中44.3%(109/249)对姑息治疗知识有限,52%(127/245)表示熟悉。
- 多数患者听到姑息治疗时感到有希望(54%)和安心(50%),83%认为转诊是医生关心的标志。
- 对姑息治疗知识更丰富的患者更可能有积极看法(B=7.54,标准误=1.61,P<.001)。
核心结论
- 造血干细胞移植受者对姑息治疗持积极看法,但许多人对姑息治疗的作用知识有限。
- 对姑息治疗知识更丰富的患者更可能有积极看法。
- 这些数据不支持移植医生关于患者对姑息治疗看法的负面担忧,并强调需要进一步教育患者和移植医生了解姑息治疗。
研究设计与样本
- 多中心横断面调查,纳入自体或异基因造血干细胞移植后3至12个月的受者。
- 评估受者对姑息治疗的熟悉度、知识、看法及未满足的姑息治疗需求。
- 计算患者对姑息治疗看法的复合评分,并使用广义线性回归模型分析相关因素。
- 入组潜在参与者的69.6%(250/359),中位年龄58.1岁,63.1%为自体造血干细胞移植。
主要发现
- 44.3%(109/249)报告对姑息治疗知识有限,52%(127/245)表示熟悉姑息治疗。
- 多数患者听到姑息治疗一词时感到有希望(54%)和安心(50%),83%认为转诊至姑息治疗表明医生关心其状况。
- 多变量分析中,对姑息治疗知识更丰富的患者更可能有积极看法(B=7.54,标准误=1.61,P<.001)。
- 患者人口学特征、造血干细胞移植特征、生活质量和症状负担与姑息治疗看法无显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Palliative care (PC) benefits patients undergoing hematopoietic stem cell transplantation (HSCT), but it remains underutilized. Although transplant physicians report concerns regarding how patients perceive PC, HSCT recipients' perceptions about PC remain unaddressed. We conducted a multisite, cross-sectional survey of autologous and allogeneic HSCT recipients 3 to 12 months after transplant to assess their familiarity, knowledge, and perception of PC, as well as their unmet PC needs. We computed a composite score of patients' perceptions of PC and used a generalized linear regression model to examine factors associated with these perceptions. We enrolled 69.6% (250/359) of potential participants (median age = 58.1; 63.1% autologous HSCT). Overall, 44.3.8% (109/249) reported limited knowledge about PC and 52% (127/245) endorsed familiarity with PC. Most patients felt hopeful (54%) and reassured (50%) when they heard the term PC; 83% saw referral as a sign their doctor cared about what was happening to them. In multivariate analyses, patients who were more knowledgeable about PC were more likely to have positive perceptions of PC (B = 7.54, standard error = 1.61, P < .001). Patients' demographics, HSCT features, quality of life, and symptom burden were not significantly associated with perceptions of PC. HSCT recipients have positive perceptions of PC, though many have limited knowledge about its role. Patients who were more knowledgeable about PC were more likely to have positive perceptions of PC. These data do not support transplant physicians' negative concerns about how patients perceive PC and underscore the need to further educate patients and transplant physicians about PC.
引用
- Barata A, Abrams HR, Meyer C, et al. What do patients think about palliative care? A national survey of hematopoietic stem cell transplant recipients. Blood Adv. 2023. PMID: 36877661. doi:10.1182/bloodadvances.2023009712
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。